Linked Life Data

19560446

Source:http://linkedlifedata.com/resource/pubmed/id/19560446

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2009-8-3
pubmed:abstractText
Sulfasalazine (SASP) pharmacologic actions are widely applied in clinical therapy. The role of N-Acetyltransferase 2 (NAT2) in the pharmacokinetics of SASP and its metabolites has not been clarified. We investigated the effects of genetic polymorphism of NAT2 on pharmacokinetic profiles of SASP and its two metabolites, sulfapyridine (SP) and N-acetylsufapyridine (AcSP).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1873-3492
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
407
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30-5
pubmed:dateRevised
2010-9-8
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population.
pubmed:affiliation
Department of Clinical Pharmacology, Jinling Hospital, Clinical School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing 210002, PR China.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't